leadf
logo-loader
viewAxim Biotechnologies, Inc.

Making a better facemask, Axim Biotech looks to be a leader protecting people from COVID-19

Axim Biotech (OTCQB: AXIM) CEO John Huemoeller joined Steve Darling from Proactive with news the company is working on a number of initiatives around protecting people from COVID-19. One of those is a much better facemask and Huemoeller explains how.

Huemoeller also told Proactvioe about a rapid test kit they are working on that will allow better screening for when people need to give the gift of life, donating blood.

Quick facts: Axim Biotechnologies, Inc.

Price: 0.4498 USD

OTCMKTS:AXIM
Market: OTCQB
Market Cap: $58.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Purepoint Uranium Group sees great opportunity as they look to develop in...

Purepoint Uranium Group (CVE: PTU) President and CEO Chris Frostad joined Steve Darling from Proactive to shared details about the company that is focused on the exploration of its projects in the Canadian Athabasca Basin, the world’s richest uranium region. Frostad telling Proactive about...

9 hours, 28 minutes ago

2 min read